Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REBECCA: A Cohort Study of Regorafenib in the Real-life Setting in Patients Previously Treated for Metastatic Colorectal Cancer.

NCT02310477 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT02310477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02310477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REBECCA: A Cohort Study of Regorafenib in the Real-life Setting in Patients Previously Treated for Metastatic Colorectal Cancer.
Lead sponsor
Centre Oscar Lambret
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
December 31, 2014
Enrollment
704 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer